Related Experiment Videos
Helium-ion-induced human cataractogenesis
E A Blakely1, I K Daftari, W J Meecham
1Lawrence Berkeley Laboratory, Berkeley, CA 94720, USA.
Summary
Helium ion therapy for intraocular melanoma can cause cataracts due to incidental lens exposure. This study examines dose-response data to understand cataract risk, relevant for space flight radiation exposure.
Area of Science:
- Ophthalmology
- Radiation Oncology
- Medical Physics
Background:
- Intraocular melanoma treatment with helium ions carries a risk of radiation-induced cataracts.
- Incidental lens exposure is often unavoidable during treatment of posterior intraocular tumors.
- Accurate dose assessment is crucial for understanding treatment complications.
Purpose of the Study:
- To analyze the exposure-response relationship for helium ion radiation and human cataract development.
- To report preliminary findings on lens opacifications and cataracts in patients treated with helium ions.
- To inform risk assessment for cataract development from radiation exposure, including space flight.
Main Methods:
- Retrospective analysis of clinical records from 347 primary intraocular melanoma patients treated with helium ions.
- Quantitative assessment of individual lenticular radiation dose and radiation quality.
- Evaluation of cataract development in 54 patients with limited lens involvement (≤10% of lens in treatment field).
Main Results:
- Preliminary results show the development of helium-ion-induced lens opacifications and cataracts in a subset of patients.
- The study focuses on patients with minimal lens exposure, providing insights into low-dose effects.
- Dose-response data is being collected for further analysis.
Conclusions:
- Helium ion therapy for intraocular melanoma can lead to cataract formation.
- Understanding the dose-response relationship is critical for managing treatment risks.
- Findings may contribute to estimating cataract risk from radiation exposure in space flight environments.